Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a note about NIH grant/contract funding and the footer revision has been updated to v3.6.6.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a small update to the study record page.SummaryDifference0.1%

- Check37 days agoChange DetectedDifference0.1%

- Check58 days agoChange DetectedThe study record updated the status to Completed with no longer recruiting and posted results; enrollment is 33 with a completion date of 2026-03-12, and results were first posted on 2026-06-03, accompanied by expanded safety and response-criteria descriptions.SummaryDifference4%

- Check65 days agoChange DetectedThe revision tag on the page advanced from v3.6.0 to v3.6.2, signaling a backend/template update; no study content changes are involved.SummaryDifference0.1%

- Check79 days agoChange DetectedNew navigation/help sections and metadata labels were added, including Last verified, Last known status was:, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and a Revision: v3.6.0 line. The previous labels and formatting (e.g., Intervention / Treatment and Revision: v3.5.5) were replaced or removed.SummaryDifference1%

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.